Damien Friel

520 total citations
15 papers, 205 citations indexed

About

Damien Friel is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Damien Friel has authored 15 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 6 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Damien Friel's work include Influenza Virus Research Studies (11 papers), Respiratory viral infections research (9 papers) and Immune Response and Inflammation (6 papers). Damien Friel is often cited by papers focused on Influenza Virus Research Studies (11 papers), Respiratory viral infections research (9 papers) and Immune Response and Inflammation (6 papers). Damien Friel collaborates with scholars based in Belgium, United States and Switzerland. Damien Friel's co-authors include Bruce L. Innis, Anne Schuind, Ping Li, Murdo Ferguson, Jyoti Soni, Nathan Segall, Louise Frenette, Robin Kroll, Corey P. Mallett and Nicolas Folschweiller and has published in prestigious journals such as The Journal of Infectious Diseases, The Lancet Infectious Diseases and Vaccine.

In The Last Decade

Damien Friel

15 papers receiving 200 citations

Peers

Countries citing papers authored by Damien Friel

Since Specialization

Citations

This map shows the geographic impact of Damien Friel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Friel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Friel more than expected).

Fields of papers citing papers by Damien Friel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Friel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Friel. The network helps show where Damien Friel may publish in the future.

Co-authorship network of co-authors of Damien Friel

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Friel. A scholar is included among the top collaborators of Damien Friel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Friel. Damien Friel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor–positive breast cancer 2025 ·JCI Insight ·(unknown), (unknown), (unknown), (unknown), Agostina Nardone, Damien Friel, Francisco Hermida‐Prado, (unknown), Genevra Kuziel, (unknown), Giorgio Gaglia, Sheheryar Kabraji, Quang‐Dé Nguyen, Sandro Santagata, Sean W. Fanning, Rinath Jeselsohn	1
2	Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity 2022 ·Vaccines ·Min Z. Levine, Crystal Holiday, Yaohui Bai, Weimin Zhong, Feng Liu, Stacie Jefferson, F. Liaini Gross, Wen‐Pin Tzeng, Louis Fries, Gale Smith, Philippe Boutet, Damien Friel, Bruce L. Innis, Corey P. Mallett, C. Todd Davis, David E. Wentworth, Ian A. York, James Stevens, Jacqueline M. Katz, Terrence M. Tumpey	6
3	Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial 2022 ·The Lancet Infectious Diseases ·Nicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, Pierre Van Damme, Adolfo Garcı́a-Sastre, Florian Krammer, Raffael Nachbagauer, Peter Palese, Alicia Solórzano, Dan Bi, Marie‐Pierre David, Damien Friel, Bruce L. Innis, (unknown), Corey P. Mallett, (unknown), Bruno Salaun, Valérie Vantomme, (unknown), Frank Struyf	17
4	Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age 2021 ·The Pediatric Infectious Disease Journal ·Joon Hyung Kim, Mamadou Dramé, Thanyawee Puthanakit, Nan‐Chang Chiu, Khuanchai Supparatpinyo, Li‐Min Huang, Cheng‐Hsun Chiu, Po‐Yen Chen, Kao‐Pin Hwang, (unknown), Damien Friel, Bruno Salaun, Wayne Woo, David W. Vaughn, Bruce L. Innis, Anne Schuind	7
5	Association Between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction–Confirmed Influenza Illness in Children 6–35 Months of Age: Statistical Evaluation of a Correlate of Protection 2021 ·Open Forum Infectious Diseases ·(unknown), Andrea Callegaro, Jyoti Soni, (unknown), (unknown), Luis Rivera, Damien Friel, Wenji Pu, Valérie Vantomme, Ghassan Dbaibo, Bruce L. Innis, Anne Schuind, Khalequ Zaman, Jerome Wilson	5
6	Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system 2020 ·Influenza and Other Respiratory Viruses ·Damien Friel, (unknown), (unknown), Bruno Salaun, Anne Schuind, Ping Li, Karl Walravens, Francis A. Ennis, David W. Vaughn	6
7	Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts 2019 ·npj Vaccines ·Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, Mohammad Amin Behzadi, Damien Friel, Arvind Rajabhathor, Angela Choi, Randy A. Albrecht, Muriel Debois, Adolfo Garcı́a-Sastre, (unknown), Weina Sun, Peter Palese, Corey P. Mallett, Bruce L. Innis, Florian Krammer, Carine Claeys	18
8	Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost 2019 ·npj Vaccines ·Min Z. Levine, Crystal Holiday, Stacie Jefferson, F. Liaini Gross, Feng Liu, Sheng Li, Damien Friel, Philippe Boutet, Bruce L. Innis, Corey P. Mallett, Terrence M. Tumpey, James Stevens, Jacqueline M. Katz	21
9	Comparison between a new multiplex electrochemiluminescence assay and the WHO reference enzyme-linked immunosorbent assay to measure serum antibodies against pneumococcal serotype-specific polysaccharides 2019 ·Vaccine ·(unknown), (unknown), (unknown), Damien Friel, Estelle Merck, Vincent Verlant, (unknown), (unknown), (unknown), (unknown), (unknown), David Goldblatt, Sonia Schoonbroodt	4
10	Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates 2019 ·The Journal of Infectious Diseases ·(unknown), Damien Friel, Emmanuel Di Paolo, Adrian Caplanusi, Paul Gillard, Michael Povey, Stéphane Carryn	8
11	Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial 2017 ·Vaccine ·(unknown), (unknown), Eric Sheldon, Louise Frenette, Laurence Chu, Damien Friel, Mamadou Dramé, David W. Vaughn, Bruce L. Innis, Anne Schuind	12
12	Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial 2017 ·Vaccine ·(unknown), Murdo Ferguson, (unknown), David Seiden, (unknown), Damien Friel, Jyoti Soni, Ping Li, Bruce L. Innis, Anne Schuind	12
13	Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial 2017 ·Vaccine ·(unknown), Murdo Ferguson, Eric Sheldon, Nathan Segall, Laurence Chu, (unknown), (unknown), Damien Friel, Jyoti Soni, Ping Li, Bruce L. Innis, Anne Schuind	10
14	Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults 2016 ·The Journal of Infectious Diseases ·(unknown), Nathan Segall, Murdo Ferguson, Louise Frenette, Robin Kroll, Damien Friel, Jyoti Soni, Ping Li, Bruce L. Innis, Anne Schuind	37
15	Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial 2015 ·Human Vaccines & Immunotherapeutics ·Ting Fan Leung, (unknown), Fong Seng Lim, Franck Thollot, Helen May Lin Oh, Bee Wah Lee, Lars Rombo, Ngiap Chuan Tan, Roman Rouzier, Damien Friel, (unknown), (unknown), P.V. Suryakiran, Marjan Hezareh, Nicolas Folschweiller, Florence Thomas, Frank Struyf	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact